Menu
The future of HIV-1 therapeutics : resistance is futile?
Enlarge

The future of HIV-1 therapeutics : resistance is futile?

Publication Data

Contents

HIV therapy
the state of ART / David Looney, Ariel Ma and Scott Johns
Computational challenges of structure-based approaches applied to HIV / Stefano Forli and Arthur J. Olson
Nucleocapsid protein: a desirable target for future therapies against HIV-1 / Mattia Mori, Lesia Kovalenko, Sébastien Lyonnais, Danny Antaki, Bruce E. Torbett, Maurizio Botta, Gilles Mirambeau and Yves Mély
HIV-1 integrase multimerization as a therapeutic target / Lei Feng, Ross C. Larue, Alison Slaughter, Jacques J. Kessl and Mamuka Kvaratskhelia
Targeting HIV transcription: the quest for a functional cure / Guillaume Mousseau, Sonia Mediouni and Susana T. Valente
Targeting the HIV RNA genome: high-hanging fruit only needs a longer ladder / Stuart F.J. Le Grice
HIV-1 gag: an emerging target for antiretroviral therapy / Philip R. Tedbury and Eric O. Freed
The triple threat of HIV-1 protease inhibitors / Marc Potempa, Sook-Kyung Lee, Richard Wolfenden and Ronald Swanstrom
Illustrations of the HIV life cycle / David S. Goodsell
Index.

Topics

Catalogue Data

ISBD

Buy a copy

OBNB doesn't sell books, but you may be able to find a copy at one of these websites:

The future of HIV-1 therapeutics : resistance is futile?. ISBN 9783319185170. Published by Springer in 2015. Publication and catalogue information, links to buy online and reader comments.

obnb.uk is a Good Stuff website.